A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections

© 2019 The British Pharmacological Society Aims: To determine statins' impact on skin infection risk in view of conflicting literature: that statins may reduce infection risk, but are also associated with diabetes mellitus, a risk factor for skin and soft tissue infections (SSTIs). Meth...

Full description

Bibliographic Details
Main Authors: Ko, Humphrey H.T., Lareu, Ricky, Dix, Brett, Hughes, Jeffery, Parsons, Richard
Format: Journal Article
Language:English
Published: WILEY 2019
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/80905
_version_ 1848764286699044864
author Ko, Humphrey H.T.
Lareu, Ricky
Dix, Brett
Hughes, Jeffery
Parsons, Richard
author_facet Ko, Humphrey H.T.
Lareu, Ricky
Dix, Brett
Hughes, Jeffery
Parsons, Richard
author_sort Ko, Humphrey H.T.
building Curtin Institutional Repository
collection Online Access
description © 2019 The British Pharmacological Society Aims: To determine statins' impact on skin infection risk in view of conflicting literature: that statins may reduce infection risk, but are also associated with diabetes mellitus, a risk factor for skin and soft tissue infections (SSTIs). Methods: Sequence symmetry analysis was performed on prescription claims (2001–2011) from the Australian Department of Veterans' Affairs to determine the interrelationships between: (i) statins and SSTIs; (ii) statins and diabetes; and (iii) diabetes and SSTIs; as well as whether statins increased the risk of SSTIs, independent of diabetes status. Chi-square tests were performed to detect differences in Index of Relative Socio-economic Advantage and Disadvantage scores of patients within each interrelationship. Prescriptions for statins, antidiabetic medication, and antistaphylococcal antibiotics were evaluated using nonidentifiable client numbers, prescription dates filled, residential electorates, and pharmaceutical codes. Adjusted sequence ratio and confidence interval were calculated at intervals of 91, 182 and 365 days for sequence symmetry analysis studies. Results: Statins were associated with: (i) significant SSTI risk (adjusted sequence ratio > 1; confidence interval >1), (ii) significant diabetes risk, and (iii) diabetic patients had increased risk of SSTIs. Diabetic and nondiabetic statin users had significantly increased risks of SSTIs, while the influence from socioeconomic status was not significant for each of the 3 relationships. Conclusions: Statins are associated with increased risk of SSTIs via direct and indirect mechanisms, probably independent of diabetes or socioeconomic statuses. We believe that clinicians should be aware of the association between statins and SSTIs, and, where appropriate, monitor blood glucose levels of statin users.
first_indexed 2025-11-14T11:16:57Z
format Journal Article
id curtin-20.500.11937-80905
institution Curtin University Malaysia
institution_category Local University
language English
last_indexed 2025-11-14T11:16:57Z
publishDate 2019
publisher WILEY
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-809052021-02-10T05:14:02Z A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections Ko, Humphrey H.T. Lareu, Ricky Dix, Brett Hughes, Jeffery Parsons, Richard Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy antibiotics diabetes pharmacoepidemiology statins COA REDUCTASE INHIBITORS SOFT-TISSUE INFECTIONS VITAMIN-D BACTERIAL SKIN GUT DYSBIOSIS PRESCRIPTION THERAPY RISK EPIDEMIOLOGY © 2019 The British Pharmacological Society Aims: To determine statins' impact on skin infection risk in view of conflicting literature: that statins may reduce infection risk, but are also associated with diabetes mellitus, a risk factor for skin and soft tissue infections (SSTIs). Methods: Sequence symmetry analysis was performed on prescription claims (2001–2011) from the Australian Department of Veterans' Affairs to determine the interrelationships between: (i) statins and SSTIs; (ii) statins and diabetes; and (iii) diabetes and SSTIs; as well as whether statins increased the risk of SSTIs, independent of diabetes status. Chi-square tests were performed to detect differences in Index of Relative Socio-economic Advantage and Disadvantage scores of patients within each interrelationship. Prescriptions for statins, antidiabetic medication, and antistaphylococcal antibiotics were evaluated using nonidentifiable client numbers, prescription dates filled, residential electorates, and pharmaceutical codes. Adjusted sequence ratio and confidence interval were calculated at intervals of 91, 182 and 365 days for sequence symmetry analysis studies. Results: Statins were associated with: (i) significant SSTI risk (adjusted sequence ratio > 1; confidence interval >1), (ii) significant diabetes risk, and (iii) diabetic patients had increased risk of SSTIs. Diabetic and nondiabetic statin users had significantly increased risks of SSTIs, while the influence from socioeconomic status was not significant for each of the 3 relationships. Conclusions: Statins are associated with increased risk of SSTIs via direct and indirect mechanisms, probably independent of diabetes or socioeconomic statuses. We believe that clinicians should be aware of the association between statins and SSTIs, and, where appropriate, monitor blood glucose levels of statin users. 2019 Journal Article http://hdl.handle.net/20.500.11937/80905 10.1111/bcp.14077 English WILEY fulltext
spellingShingle Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
antibiotics
diabetes
pharmacoepidemiology
statins
COA REDUCTASE INHIBITORS
SOFT-TISSUE INFECTIONS
VITAMIN-D
BACTERIAL SKIN
GUT DYSBIOSIS
PRESCRIPTION
THERAPY
RISK
EPIDEMIOLOGY
Ko, Humphrey H.T.
Lareu, Ricky
Dix, Brett
Hughes, Jeffery
Parsons, Richard
A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
title A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
title_full A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
title_fullStr A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
title_full_unstemmed A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
title_short A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
title_sort sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections
topic Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
antibiotics
diabetes
pharmacoepidemiology
statins
COA REDUCTASE INHIBITORS
SOFT-TISSUE INFECTIONS
VITAMIN-D
BACTERIAL SKIN
GUT DYSBIOSIS
PRESCRIPTION
THERAPY
RISK
EPIDEMIOLOGY
url http://hdl.handle.net/20.500.11937/80905